Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Clin Infect Dis ; 77(Suppl 1): S118-S124, 2023 07 05.
Artículo en Inglés | MEDLINE | ID: mdl-37406054

RESUMEN

BACKGROUND: Low- and middle-income countries bear a disproportionate burden of antimicrobial resistance (AMR) but often lack adequate surveillance to inform mitigation efforts. Colonization can be a useful metric to understand AMR burden. We assessed the colonization prevalence of Enterobacterales with resistance to extended-spectrum cephalosporins, carbapenems, colistin, and methicillin-resistant Staphylococcus aureus among hospital and community dwellers. METHODS: Between April and October 2019, we conducted a period prevalence study in Dhaka, Bangladesh. We collected stool and nasal specimens from adults in 3 hospitals and from community dwellers within the hospitals' catchment area. Specimens were plated on selective agar plates. Isolates underwent identification and antibiotic susceptibility testing using Vitek 2. We performed descriptive analysis and determined population prevalence estimates accounting for clustering at the community level. RESULTS: The majority of both community and hospital participants were colonized with Enterobacterales with resistance to extended-spectrum cephalosporins (78%; 95% confidence interval [95% CI], 73-83; and 82%; 95% CI, 79-85, respectively). Thirty-seven percent (95% CI, 34-41) of hospitalized patients were colonized with carbapenems compared with 9% (95% CI, 6-13) of community individuals. Colistin colonization prevalence was 11% (95% CI, 8-14) in the community versus 7% (95% CI, 6-10) in the hospital. Methicillin-resistant Staphylococcus aureus colonization was similar in both community and hospital participants (22%; 95% CI, 19-26 vs 21% (95% CI, 18-24). CONCLUSIONS: The high burden of AMR colonization observed among hospital and community participants may increase the risk for developing AMR infections and facilitating spread of AMR in both the community and hospital.


Asunto(s)
Staphylococcus aureus Resistente a Meticilina , Infecciones Estafilocócicas , Adulto , Humanos , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Prevalencia , Colistina , Bangladesh/epidemiología , Hospitales , Carbapenémicos , Cefalosporinas , Farmacorresistencia Microbiana , Infecciones Estafilocócicas/tratamiento farmacológico , Infecciones Estafilocócicas/epidemiología
2.
Am J Trop Med Hyg ; 103(3): 1039-1042, 2020 09.
Artículo en Inglés | MEDLINE | ID: mdl-32588814

RESUMEN

Chromobacterium violaceum is an emerging environmental pathogen that causes life-threatening infection in humans and animals. In October 2017, a Bangladeshi farmer was hospitalized with high-grade fever due to an agricultural injury-related wound infection. Bacteriological and 16S rRNA gene investigation detected C. violaceum in the wound discharge. The patient recovered successfully after a combination treatment with meropenem and ciprofloxacin, followed by prolonged medication to avoid recurrence. We strongly propose to incorporate C. violaceum in the differential diagnosis of wound and skin infections occurring in tropical and subtropical regions, especially when the injury was exposed to soil or sluggish water.


Asunto(s)
Chromobacterium/patogenicidad , Ciprofloxacina/uso terapéutico , Meropenem/uso terapéutico , Infecciones por Neisseriaceae/tratamiento farmacológico , Sepsis/tratamiento farmacológico , Infección de Heridas/tratamiento farmacológico , Adulto , Antibacterianos/uso terapéutico , Técnicas de Tipificación Bacteriana , Chromobacterium/clasificación , Chromobacterium/efectos de los fármacos , Chromobacterium/genética , Agricultores , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Infecciones por Neisseriaceae/microbiología , Infecciones por Neisseriaceae/patología , Filogenia , ARN Ribosómico 16S/genética , Sepsis/microbiología , Sepsis/patología , Resultado del Tratamiento , Infección de Heridas/microbiología , Infección de Heridas/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA